Heptasilin Tablet is a combination pharmaceutical formulation designed to support liver function and promote hepatic regeneration. It contains Metadoxine (500 mg), a hepatoprotective agent known for its efficacy in accelerating the metabolism of alcohol and reducing oxidative stress in hepatic tissues. Silymarin (140 mg), a flavonoid complex extracted from milk thistle, exhibits potent antioxidant, anti-inflammatory, and antifibrotic properties, contributing to the stabilization of hepatocyte membranes and enhancement of liver detoxification processes. L-Ornithine L-Aspartate (150 mg) serves as an ammonia scavenger, facilitating the detoxification of ammonia and improving hepatic encephalopathy symptoms by promoting the urea cycle. Vitamin B6 (Pyridoxine, 3 mg) is included to support enzymatic reactions essential for amino acid metabolism and neurotransmitter synthesis, while Folic Acid (1.5 mg) aids in nucleic acid synthesis and cellular repair mechanisms. The synergistic action of these components makes Heptasilin Tablet effective in managing various liver disorders, including alcoholic liver disease, hepatic encephalopathy, and non-alcoholic fatty liver disease. It is indicated as an adjunct therapy to improve liver function tests, reduce hepatic inflammation, and enhance overall liver health. Administration should follow medical guidance, considering patient-specific factors and contraindications.